Trial Profile
A Randomized Double Blind Placebo Controlled Trial of Ramelteon in the Prevention of Post-operative Delirium in Older Patients Undergoing Orthopedic Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary) ; Riboflavin
- Indications Delirium
- Focus Therapeutic Use
- Acronyms RECOVER
- 27 Jun 2019 Status changed from recruiting to completed.
- 24 Aug 2017 Planned End Date changed from 1 Mar 2020 to 30 Jun 2019.
- 24 Aug 2017 Planned primary completion date changed from 1 Mar 2019 to 30 Jun 2019.